BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28626969)

  • 1. Different patterns of expression of cell cycle control and local invasion-related proteins in oral squamous cell carcinoma affecting young patients.
    Miranda Galvis M; Santos-Silva AR; Freitas Jardim J; Paiva Fonseca F; Lopes MA; de Almeida OP; Lópes Pinto CA; Kaminagakura E; Sawazaki-Calone I; Speight PM; Kowalski LP
    J Oral Pathol Med; 2018 Jan; 47(1):32-39. PubMed ID: 28626969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma.
    Monteiro LS; Diniz-Freitas M; Garcia-Caballero T; Warnakulasuriya S; Forteza J; Fraga M
    J Oral Pathol Med; 2012 Aug; 41(7):559-67. PubMed ID: 22417132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray study.
    Solomon MC; Vidyasagar MS; Fernandes D; Guddattu V; Mathew M; Shergill AK; Carnelio S; Chandrashekar C
    Med Oncol; 2016 Dec; 33(12):138. PubMed ID: 27817107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative analysis of gene alterations and immunoexpression profiles of cell cycle checkpoints in oral squamous cell carcinoma.
    Pérez-Sayáns M; Chamorro-Petronacci CM; Lorenzo-Pouso AI; Peñaranda JMS; López-López J; Blanco-Carrión A; García-García A
    Cancer Biomark; 2020; 27(1):95-103. PubMed ID: 31683463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The unexplained survival of cells in oral cancer: what is the role of p53?
    Whyte DA; Broton CE; Shillitoe EJ
    J Oral Pathol Med; 2002 Mar; 31(3):125-33. PubMed ID: 11903817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence.
    Sawair F; Hassona Y; Irwin C; Stephenson M; Hamilton P; Maxwell P; Gordon D; Leonard A; Napier S
    Asian Pac J Cancer Prev; 2016; 17(3):1243-9. PubMed ID: 27039754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma.
    Jayasurya R; Francis G; Kannan S; Lekshminarayanan K; Nalinakumari KR; Abraham T; Abraham EK; Nair MK
    Int J Cancer; 2004 May; 109(5):710-6. PubMed ID: 14999779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
    Nemes JA; Nemes Z; Márton IJ
    J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast.
    Lebeau A; Unholzer A; Amann G; Kronawitter M; Bauerfeind I; Sendelhofert A; Iff A; Löhrs U
    Breast Cancer Res Treat; 2003 May; 79(2):187-98. PubMed ID: 12825853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
    Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
    Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
    PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma.
    Perisanidis C; Perisanidis B; Wrba F; Brandstetter A; El Gazzar S; Papadogeorgakis N; Seemann R; Ewers R; Kyzas PA; Filipits M
    J Oral Pathol Med; 2012 Jan; 41(1):40-6. PubMed ID: 21883486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis.
    Uchida F; Uzawa K; Kasamatsu A; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Bukawa H; Tanzawa H
    PLoS One; 2013; 8(2):e56381. PubMed ID: 23418564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoexpression and prognostic significance of TIMP-1 and -2 in oral squamous cell carcinoma.
    de Vicente JC; Fresno MF; Villalain L; Vega JA; López Arranz JS
    Oral Oncol; 2005 Jul; 41(6):568-79. PubMed ID: 15925538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas.
    da Silva SD; Cunha IW; Nishimoto IN; Soares FA; Carraro DM; Kowalski LP; Graner E
    Oral Oncol; 2009 Oct; 45(10):e134-9. PubMed ID: 19362044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profile of apoptotic mediators and proliferative markers in oral squamous cell carcinoma.
    Ahmed MM
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):85-92. PubMed ID: 21057559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of EGFR and cyclin D1 genes associated with human papillomavirus infection in oral squamous cell carcinoma.
    Chuerduangphui J; Pientong C; Patarapadungkit N; Chotiyano A; Vatanasapt P; Kongyingyoes B; Promthet S; Swangphon P; Bumrungthai S; Pimson C; Ekalaksananan T
    Med Oncol; 2017 Sep; 34(9):148. PubMed ID: 28741068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion.
    Pramanik KK; Nagini S; Singh AK; Mishra P; Kashyap T; Nath N; Alam M; Rana A; Mishra R
    Cell Oncol (Dordr); 2018 Feb; 41(1):47-60. PubMed ID: 29134466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53, mdm2, and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors.
    Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Nov; 94(5):593-600. PubMed ID: 12424454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.